Introduction Berberine and metformin are two pharmacological agents widely used in the management of metabolic disorders, particularly type 2 diabetes mellitus (T2DM) and polycystic ovary syndrome (PCOS). Both compounds have demonstrated significant effects on glucose metabolism and insulin sensitivity, yet they differ in their pharmacokinetics, mechanisms of action, and clinical applications. This article aims to…